Journal of Inflammation ResearchIan N Foltz,1 Kevin Gaida,2 Helen Y Wong,1 Michael Ng,1 Marijana Busch,1 Jennifer L Liu3 1Amgen Research, Department of Therapeutic Discovery, Amgen Inc., Burnaby, BC, V5A1V7, Canada; 2Research and Development, Amgen Inc., Thousand Oaks, CA, 91320, USA ...
Foltz IN +5 more
doaj
Manufacturing of Recombinant Human Follicle-Stimulating Hormone Ovaleap (XM17), Comparability with Gonal-f, and Performance/Consistency [PDF]
, 2017 core +1 more source
Sandoz Inc. v. Amgen Inc.: Removing Barriers to Market Access for Biosimilar Manufacturers [PDF]
, 2019 Koya, Moyosore O.
core +1 more source
Evolution of Approaches to the Development, Life Cycle Control, and Interchangeability of Veterinary Biosimilars Based on Hemoproteins (with a Focus on Cytochrome C). [PDF]
Pharmaceuticals (Basel)Ponamarev VS.
europepmc +1 more source
Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial. [PDF]
Cardiovasc Diabetol Endocrinol RepGhosh S +9 more
europepmc +1 more source
Toward Regulatory Convergence and Streamlined Biosimilar Development: Recommendations from an International Qualitative Study. [PDF]
BioDrugsCar E +5 more
europepmc +1 more source
Drugs anticipated to be selected for Medicare price negotiation in 2026 for implementation in 2028. [PDF]
J Manag Care Spec PharmCousin EM +4 more
europepmc +1 more source
Evaluation of a New Potential Bevacizumab Biosimilar in Corneal Neovascularization. [PDF]
Turk J OphthalmolÖzgür A +4 more
europepmc +1 more source
Biosimilar Versus Innovator Ranibizumab in Myopic CNVM: Comparative Real-World Outcomes- The BRIM Study. [PDF]
Clin OphthalmolChakraborty D +7 more
europepmc +1 more source